1. A randomized, double‐blind, placebo‐controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder. (11th September 2022) Authors: Seneviratne, Chamindi; Gorelick, David A.; Lynch, Kevin G.; Brown, Clayton; Romer, Danielle; Pond, Timothy; Kampman, Kyle; Kranzler, Henry R. Journal: Alcoholism Issue: Volume 46:Number 10(2022) Page Start: 1900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder. (1st August 2021) Authors: Kranzler, Henry R.; Hartwell, Emily E.; Feinn, Richard; Pond, Timothy; Witkiewitz, Katie; Gelernter, Joel; Crist, Richard C. Journal: Drug and alcohol dependence Issue: Volume 225(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals. (September 2017) Authors: Douglas-Newman, Kara R.; Smith, Rachel V.; Spiers, Mary V.; Pond, Timothy; Kranzler, Henry R. Journal: Addictive disorders & their treatment Issue: Volume 16:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Posttreatment Effects of Topiramate Treatment for Heavy Drinking. (7th January 2015) Authors: Kranzler, Henry R.; Wetherill, Reagan; Feinn, Richard; Pond, Timothy; Gelernter, Joel; Covault, Jonathan Journal: Alcoholism Issue: Volume 38:Number 12(2014:Dec.) Page Start: 3017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Posttreatment Effects of Topiramate Treatment for Heavy Drinking. (December 2014) Authors: Kranzler, Henry R.; Wetherill, Reagan; Feinn, Richard; Pond, Timothy; Gelernter, Joel; Covault, Jonathan Journal: Alcoholism Issue: Volume 38:Number 12(2014:Dec.) Page Start: 3017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Post‐treatment effects of topiramate on alcohol‐related outcomes: A combined analysis of two placebo‐controlled trials. (25th January 2022) Authors: Kranzler, Henry R.; Feinn, Richard; Pond, Timothy; Hartwell, Emily; Gelernter, Joel; Crist, Richard C.; Witkiewitz, Katie Journal: Addiction biology Issue: Volume 27:Number 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Self‐efficacy mediates the effects of topiramate and GRIK1 genotype on drinking. (15th December 2014) Authors: Kranzler, Henry R.; Armeli, Stephen; Wetherill, Reagan; Feinn, Richard; Tennen, Howard; Gelernter, Joel; Covault, Jonathan; Pond, Timothy Journal: Addiction biology Issue: Volume 21:Number 2(2016) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Smoking and Cellular Telephone Use Among Pregnant Women Seeking Prenatal Care: Opportunities for Intervention. (December 2015) Authors: Gilbert, Jennifer; Schnoll, Robert; Morrison, Mary F.; Srinivas, Sindhu K.; Pond, Timothy; Curtis, Brenda; Henry, Jennifer; Kranzler, Henry R. Journal: Addictive disorders & their treatment Issue: Volume 14:Number 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials. (5th July 2021) Authors: Hartwell, Emily E.; Feinn, Richard; Witkiewitz, Katie; Pond, Timothy; Kranzler, Henry R. Journal: Alcoholism Issue: Volume 45:Number 8(2021) Page Start: 1664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗